BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26385834)

  • 1. Human immunodeficiency virus type 1 splicing at the major splice donor site is controlled by highly conserved RNA sequence and structural elements.
    Mueller N; Klaver B; Berkhout B; Das AT
    J Gen Virol; 2015 Nov; 96(11):3389-3395. PubMed ID: 26385834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.
    Kammler S; Leurs C; Freund M; Krummheuer J; Seidel K; Tange TO; Lund MK; Kjems J; Scheid A; Schaal H
    RNA; 2001 Mar; 7(3):421-34. PubMed ID: 11333022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 splicing at the major splice donor site is restricted by RNA structure.
    Mueller N; van Bel N; Berkhout B; Das AT
    Virology; 2014 Nov; 468-470():609-620. PubMed ID: 25305540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 splicing is controlled by local RNA structure and binding of splicing regulatory proteins at the major 5' splice site.
    Mueller N; Berkhout B; Das AT
    J Gen Virol; 2015 Jul; 96(Pt 7):1906-17. PubMed ID: 25779589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV-1 Tat Protein Enhances Splicing at the Major Splice Donor Site.
    Mueller N; Pasternak AO; Klaver B; Cornelissen M; Berkhout B; Das AT
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive RNA splicing and inhibition of HIV-1 replication induced by modified U1 small nuclear RNAs.
    Mandal D; Feng Z; Stoltzfus CM
    J Virol; 2010 Dec; 84(24):12790-800. PubMed ID: 20926575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phylogenetic Survey on the Structure of the HIV-1 Leader RNA Domain That Encodes the Splice Donor Signal.
    Mueller N; Das AT; Berkhout B
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27455303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.
    Exline CM; Feng Z; Stoltzfus CM
    J Virol; 2008 Apr; 82(8):3921-31. PubMed ID: 18272582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing.
    Jacquenet S; Ropers D; Bilodeau PS; Damier L; Mougin A; Stoltzfus CM; Branlant C
    Nucleic Acids Res; 2001 Jan; 29(2):464-78. PubMed ID: 11139617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability.
    Lützelberger M; Reinert LS; Das AT; Berkhout B; Kjems J
    J Biol Chem; 2006 Jul; 281(27):18644-51. PubMed ID: 16675444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended base pair complementarity between U1 snRNA and the 5' splice site does not inhibit splicing in higher eukaryotes, but rather increases 5' splice site recognition.
    Freund M; Hicks MJ; Konermann C; Otte M; Hertel KJ; Schaal H
    Nucleic Acids Res; 2005; 33(16):5112-9. PubMed ID: 16155183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor.
    Abbink TE; Berkhout B
    J Virol; 2008 Mar; 82(6):3090-8. PubMed ID: 18160437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing.
    Hibbert CS; Gontarek RR; Beemon KL
    RNA; 1999 Mar; 5(3):333-43. PubMed ID: 10094303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of modified U1 snRNAs to inhibit HIV-1 replication.
    Sajic R; Lee K; Asai K; Sakac D; Branch DR; Upton C; Cochrane A
    Nucleic Acids Res; 2007; 35(1):247-55. PubMed ID: 17158512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to describe a U1 snRNA binding site.
    Freund M; Asang C; Kammler S; Konermann C; Krummheuer J; Hipp M; Meyer I; Gierling W; Theiss S; Preuss T; Schindler D; Kjems J; Schaal H
    Nucleic Acids Res; 2003 Dec; 31(23):6963-75. PubMed ID: 14627829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.
    Madsen JM; Stoltzfus CM
    Retrovirology; 2006 Feb; 3():10. PubMed ID: 16457729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.
    Erkelenz S; Poschmann G; Theiss S; Stefanski A; Hillebrand F; Otte M; Stühler K; Schaal H
    J Virol; 2013 Mar; 87(5):2721-34. PubMed ID: 23255807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U1-like snRNAs lacking complementarity to canonical 5' splice sites.
    Kyriakopoulou C; Larsson P; Liu L; Schuster J; Söderbom F; Kirsebom LA; Virtanen A
    RNA; 2006 Sep; 12(9):1603-11. PubMed ID: 16829670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of a cryptic splice donor in human immunodeficiency virus type-1.
    Borg KT; Favaro JP; Arrigo SJ; Schmidt M
    J Biomed Sci; 1999 Jan; 6(1):45-52. PubMed ID: 9933742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.